Refine
Has Fulltext
- yes (12)
Is part of the Bibliography
- yes (12)
Year of publication
Document Type
- Journal article (12) (remove)
Language
- English (12) (remove)
Keywords
- myelin (3)
- Neurodegeneration (2)
- Neuronal ceroid lipofuscinosis (2)
- T-lymphocytes (2)
- glial fate modulation (2)
- neuroimmunology (2)
- neuroinflammation (2)
- transplantation (2)
- Axon degeneration (1)
- B-lymphocytes (1)
- Charcot-Marie-Tooth (1)
- DYT1 (1)
- Dystonia (1)
- Fc-receptor (1)
- Lysosomal storage disease (1)
- Macrophages (1)
- Microglia (1)
- Optical coherence tomography (1)
- Parkinson's disease (1)
- Retinal degeneration (1)
- Schwann cell differentiation (1)
- T lymphocytes (1)
- TIMP-1 (1)
- adaptive immune system (1)
- antibodies (1)
- antigen-presenting cells (1)
- attenuation of disease (1)
- axonal degeneration (1)
- axonopathic changes (1)
- colony stimulating factor 1 (1)
- complement (1)
- degeneration (1)
- demyelination (1)
- diseases of the nervous system (1)
- dopamine (1)
- experimental autoimmune encephalomyelitis (1)
- granzyme B (1)
- immunomodulation (1)
- infantile neuronal ceroid lipofuscinosis (1)
- inflammation (1)
- inherited peripheral neuropathy (1)
- macrophage (1)
- macrophages (1)
- mesenchymal stem cells (1)
- motor function (1)
- multiple sclerosis (1)
- myelin biology and repair (1)
- nervous system (1)
- neural apoptosis (1)
- neural stem cell (1)
- neural stem cells (1)
- neurodegeneration (1)
- oligodendroglia (1)
- p57kip2 (1)
- peripheral injury (1)
- preventive treatment (1)
- proteolipid protein (1)
- proteolipid protein gene (1)
- regional heterogeneity (1)
- retinal ganglion cells (1)
- second hit (1)
- secretome (1)
- spinal cord (1)
- spinal cord injury (1)
- teriflunomide (1)
Institute
Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1B
(2015)
Background
We could previously identify components of both the innate and the adaptive immune system as disease modifiers in the pathogenesis of models for Charcot-Marie-Tooth (CMT) neuropathies type 1B and 1X. As part of the adaptive immune system, here we investigated the role of antibodies in a model for CMT1B.
Methods
Antibodies were localized and characterized in peripheral nerves of the CMT1B model by immunohistochemistry and Western blot analysis. Experimental ablation of antibodies was performed by cross breeding the CMT1B models with mutants deficient in B-lymphocytes (JHD−/− mutants). Ameliorated demyelination by antibody deficiency was reverted by intravenous injection of mouse IgG fractions. Histopathological analysis was performed by immunocytochemistry and light and quantitative electron microscopy.
Results
We demonstrate that in peripheral nerves of a mouse model for CMT1B, endogenous antibodies strongly decorate endoneurial tubes of peripheral nerves. These antibodies comprise IgG and IgM subtypes and are preferentially, but not exclusively, associated with nerve fiber aspects nearby the nodes of Ranvier. In the absence of antibodies, the early demyelinating phenotype is substantially ameliorated. Reverting the neuropathy by reconstitution with murine IgG fractions identified accumulating antibodies as potentially pathogenic at this early stage of disease.
Conclusions
Our study demonstrates that in a mouse model for CMT1B, endogenous antibodies contribute to early macrophage-mediated demyelination and disease progression. Thus, both the innate and adaptive immune system are mutually interconnected in a genetic model for demyelination. Since in Wallerian degeneration antibodies have also been shown to be involved in myelin phagocytosis, our study supports our view that inherited demyelination and Wallerian degeneration share common mechanisms, which are detrimental when activated under nonlesion conditions.
Introduction
The neuronal ceroid lipofuscinoses constitute a group of fatal inherited lysosomal storage diseases that manifest in profound neurodegeneration in the CNS. Visual impairment usually is an early symptom and selective degeneration of retinal neurons has been described in patients suffering from distinct disease subtypes. We have previously demonstrated that palmitoyl protein thioesterase 1 deficient (Ppt1-/-) mice, a model of the infantile disease subtype, exhibit progressive axonal degeneration in the optic nerve and loss of retinal ganglion cells, faithfully reflecting disease severity in the CNS. Here we performed spectral domain optical coherence tomography (OCT) in Ppt1-/- and ceroid lipofuscinosis neuronal 3 deficient (Cln3-/-) mice, which are models of infantile and juvenile neuronal ceroid lipofuscinosis, respectively, in order to establish a non-invasive method to assess retinal alterations and monitor disease severity in vivo.
Results
Blue laser autofluorescence imaging revealed increased accumulation of autofluorescent storage material in the inner retinae of 7-month-old Ppt1-/- and of 16-month-old Cln3-/- mice in comparison with age-matched control littermates. Additionally, optical coherence tomography demonstrated reduced thickness of retinae in knockout mice in comparison with age-matched control littermates. High resolution scans and manual measurements allowed for separation of different retinal composite layers and revealed a thinning of layers in the inner retinae of both mouse models at distinct ages. OCT measurements correlated well with subsequent histological analysis of the same retinae.
Conclusions
These results demonstrate the feasibility of OCT to assess neurodegenerative disease severity in mouse models of neuronal ceroid lipofuscinosis and might have important implications for diagnostic evaluation of disease progression and therapeutic efficacy in patients. Moreover, the non-invasive method allows for longitudinal studies in experimental models, reducing the number of animals used for research.